Biopure submits Hemopure BLA

BPUR submitted a BLA to the FDA for Hemopure hemoglobin glutamer (HBOC-201) to treat anemia in adults undergoing orthopedic surgery, and to eliminate or reduce red blood cell transfusions in these pat...